Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's Krystal Biotech, Inc. (KRYS) position

Yes: as of Q1 2026, Jim Simons holds 10K shares of KRYS worth $2.5M (0.0% of the disclosed portfolio). Last quarter the position was increased by 190.9%. First disclosed Q3 2021.
View full portfolio →
Current value
$2.5M
Shares held
10K
% of portfolio
0.0%
Est. average buy price (i)
$247.15
Quarter-end price
$258.32

Estimated trade prices

Average price in quarters with purchases
$137.64
Average prices in quarters with sales
  • Q4 2024: $177.39 (4K shares sold)

KRYS price vs Simons's position

1Y 3Y 5Y MAX
Dates
$40$200$40020222023202420252026New position of 33K shares · Q3 2021. Average closing price $59.20 · Price range $52.01–$71.7733KsharespurchasedNew position of 25K shares · Q1 2024. Average closing price $138.91 · Price range $108.01–$179.3525KsharespurchasedNew position of 14K shares · Q3 2024. Average closing price $192.81 · Price range $174.70–$213.6614KsharespurchasedSold 4K shares (24.3%) · Q4 2024. Average closing price $177.39 · Price range $156.64–$199.614KsharessoldAdded 300 shares (2.8%) · Q1 2025. Average closing price $168.21 · Price range $142.64–$194.44300sharespurchasedAdded 79K shares (701.8%) · Q2 2025. Average closing price $146.88 · Price range $123.36–$181.0079KsharespurchasedNew position of 3K shares · Q4 2025. Average closing price $210.47 · Price range $179.61–$253.683KsharespurchasedAdded 6K shares (190.9%) · Q1 2026. Average closing price $266.36 · Price range $244.71–$297.386Ksharespurchased
Average closing price · filing quarter
$266.36
Price range · filing quarter
$244.71 – $297.38
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +6K +$1.7M +190.9% 10K May 14, 2026
Q4 2025 New +3K +$695K – 3K Feb 12, 2026
Q2 2025 Added +79K +$12M +701.8% 90K Aug 13, 2025
Q1 2025 Added +300 +$50K +2.8% 11K May 14, 2025
Q4 2024 Reduced −4K −$621K −24.3% 11K Feb 13, 2025
Q3 2024 New +14K +$2.8M – 14K Nov 13, 2024
Q1 2024 New +25K +$3.4M – 25K May 13, 2024
Q3 2021 New +33K +$2.0M – 33K Nov 12, 2021
Data through Q1 2026 · filed May 14, 2026
8 grouped rows from 8 quarters

More Simons positions

United Therapeutics Corporation(UTHR)
$1.1B
1.7% of portfolio

Palantir Technologies Inc.(PLTR)
$997M
1.6% of portfolio

Apple Inc.(AAPL)
$778M
1.2% of portfolio

Kinross Gold Corporation(KGC)
$780M
1.2% of portfolio

Micron Technology, Inc.(MU)
$731M
1.1% of portfolio

VeriSign, Inc.(VRSN)
$700M
1.1% of portfolio

Common questions

Does Jim Simons own KRYS?

Yes. As of Q1 2026, Jim Simons disclosed 10K shares of KRYS, worth $2.5M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy KRYS?

Jim Simons first disclosed a KRYS position in Q3 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell KRYS?

The quarter-by-quarter table above shows each sale and reduction Jim Simons disclosed in KRYS. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of KRYS does Jim Simons own?

Jim Simons disclosed 10K shares of KRYS as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for KRYS?

Jim Simons's estimated average buy price for KRYS is $247.15, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.